SPZ treatment resulted in a lesser but still highly significant inhibition with 62.1 ± 3.0% residual enzyme activity (Fig. 3 D).
← all excerpts
Phenotypical and functional characterization of a HepG2 cell clone stably overexpressing cytochrome P450 (CYP) 2C9.
1
—
—